<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139485">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01822782</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2013/LB-01</org_study_id>
    <nct_id>NCT01822782</nct_id>
  </id_info>
  <brief_title>Abnormal Vaginal Flora and Vaginal Lesions at Delivery: is There a Relationship?</brief_title>
  <official_title>Abnormal Vaginal Flora and Vaginal Lesions at Delivery: is There a Relationship?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to assess whether the presence of abnormal vaginal flora
      (intermediate flora or vaginosis) is a risk factor for vaginal lesions at the time of
      delivery. For this, the primary endpoint will be the proportion of vaginal lesions according
      to the presence or absence of abnormal vaginal flora.

      A more precise qualitative and quantitative study of vaginal flora isolated from pregnant
      women and its association with vaginal lesions will also be conducted.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Presence/absence of a vaginal lesion due to delivery</measure>
    <time_frame>Upon delivery (Day 0)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Record of abnormal vaginal flora (presence/absence of Nugent's score &gt; 3) in patient's medical file</measure>
    <time_frame>Upon delivery (Day 0)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Record of routine analysis of vaginal samples during pregnancy will be used.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recorded qualitative and quantitative analysis of vaginal flora in patient's file</measure>
    <time_frame>Upon delivery (Day 0)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1100</enrollment>
  <condition>Vaginal Lesion</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>The study population consists of all consecutive women meeting inclusion/exclusion criteria and delivering at the Nîmes University Hospital, France during an inclusion period of 6 months. &quot;Cases&quot; are classified as those with a vaginal lesion due to delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>The study population consists of all consecutive women meeting inclusion/exclusion criteria and delivering at the Nîmes University Hospital, France during an inclusion period of 6 months. &quot;Controls&quot; are classified as those without a vaginal lesion due to delivery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bacteriological analysis of vaginal sample</intervention_name>
    <description>Bacteriological analysis of vaginal sample</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of all consecutive women meeting inclusion/exclusion
        criteria and delivering at the Nîmes University Hospital, France during an inclusion
        period of 6 months.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women with a gestational age &gt; 34 weeks delivering at the Nîmes University
             Hospital

        Exclusion Criteria:

          -  Patient under judicial protection

          -  Adult patient under any kind of guardianship

          -  Patient refuses participation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurie Becerra, Sage Femme</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Philippe Lavigne, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 9</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 3, 2014</lastchanged_date>
  <firstreceived_date>March 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Perineal tear</keyword>
  <keyword>Perineal lesion</keyword>
  <keyword>Vaginal flora</keyword>
  <keyword>Birth</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
